| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pharmacology, Tulane University Health Sciences Center, New Orleans, LA, USA
2 Pharmacology, Tulane University Health Sciences Center, New Orleans, LA, USA; Urology, Tulane University Health Sciences Center, New Orleans, LA, USA
3 Structural and Cellular Biology, Tulane University Health Sciences Center, New Orleans, LA, USA
* To whom correspondence should be addressed. E-mail: aahyman{at}tulane.edu.
Endothelial nitric oxide synthase (eNOS) is an attractive target for cardiovascular gene therapy. Marrow stromal cells (MSCs), also known as mesenchymal stem cells, hold great promise for use in adult stem cell-based cell and gene therapy. To determine the feasibility of adenoviral-mediated eNOS gene transfer into ex vivo expanded MSCs, rat marrow stromal cells (rMSCs) were isolated, expanded ex vivo, and transduced with Ad5RSVeNOS, an adenoviral vector containing the eNOS gene under the control of the RSV promoter. The presence of eNOS protein in Ad5RSVeNOS-transduced rMSCs was confirmed by immunocytochemical and Western blot analysis. Transduction efficiency was dose-dependent and eNOS transgene expression in rMSCs persisted for at least 21 days in culture. The rMSCs retained multipotential differentiation capability after adenoviral-mediated eNOS gene transfer. Further, intracavernosal injection of Ad5RSVeNOS-transduced rMSCs increased the expression of eNOS in the corpus cavernosum and stem cells were identified within corporal sinusoids. These findings demonstrate that replication-deficient recombinant adenovirus can be used to engineer ex vivo expanded rMSCs and that high level eNOS transgene expression can be achieved, pointing out the clinical potential of using this novel adult stem cell-based gene therapy method for the treatment of cardiovascular diseases.
This article has been cited by other articles:
|
|
 |
|
  T. J. Bivalacqua, W. Deng, M. Kendirci, M. F. Usta, C. Robinson, B. K. Taylor, S. N. Murthy, H. C. Champion, W. J. G. Hellstrom, and P. J. Kadowitz Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1278 - H1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, R. Cade, and Z. Sun Human eNOS gene delivery attenuates cold-induced elevation of blood pressure in rats Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1161 - H1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Haider and M. Ashraf Bone marrow stem cell transplantation for cardiac repair Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
